Opioids Can Be Continued in Cancer Patients With Nonmedical Stimulant Use
Regardless of prognosis, panel deemed it appropriate to continue opioids, increase monitoring, and avoid opioid tapering
Regardless of prognosis, panel deemed it appropriate to continue opioids, increase monitoring, and avoid opioid tapering
Non-English-speaking patient callers to hospital are less likely to be provided with next steps to access cancer care
Report highlights advances such as approval of 14 new anticancer therapeutics, expansion of use of 12 previously approved therapeutics
Main risk factors underlying early-onset cancers are dietary risk factors, alcohol consumption, and tobacco use
Younger patients, African American patients appear to have more cost-related delays/nonadherence
Significant reduction also seen in obesity-related cancer incidence and in cancer mortality after bariatric surgery
A cancer patient’s race, type of insurance, and setting in which they are treated are all associated with end-of-life treatment, a study suggests.
MBIs recommended for anxiety symptoms and depression symptoms during and after cancer treatment
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations
Estimated rate of mortality due to solid cancer increased by 52 percent per Gy with cumulative dose, lagged by 10 years